A note of caution amidst a 'revolution' in hepatitis C treatment

August 10, 2017 by Clare Morgan, University of New South Wales
A note of caution amidst a ‘revolution’ in hepatitis C treatment
Credit: University of New South Wales

As new treatments for hepatitis C reshape the landscape, new data from UNSW underscore the need to address issues including discrimination, stigma and engaging marginalised communities.

Tens of thousands of Australians have been cured of Hepatitis C since new treatments were made universally available last year, and a report released last month said Australia is on track to eliminate C by 2026.

But while new treatments continue to dramatically reshape the landscape, data from the Centre for Social Research in Health's (CSRH) Annual Report of Trends in Behaviour 2017: Viral Hepatitis in Australia underscores the need for caution.

Addressing stigma in healthcare settings, engaging marginalised communities in prevention, and continuing to trial innovative models of care will all be imperative if the 'new era' of treatment is to fulfil its promise, the report says.

It also notes the challenges of dealing with hepatitis B: about one third of people living with the disease are yet to be diagnosed and only 6% have been treated.

The report was presented on 10 August at the Australasian Viral Hepatitis Elimination Conference (AVHEC) in Cairns.

The Annual Report of Trends in Behaviour presents data from a selection of the behavioural and social research conducted by the CSRH. It is designed to inform prevention, diagnosis and treatment by critiquing and questioning the assumptions that sometimes underlie research, policy and practice around viral hepatitis.

Key issues in the 2017 report on viral hepatitis include:

  • The need to continually innovate harm reduction programs in ways that reflect how transmission happens in the everyday
  • Exploring best models of care for affected communities
  • The impact of stigma on the capacity of affected communities to navigate treatment systems
  • Understanding and preventing hepatitis C transmission within heterosexual couples
  • Examining strategies beyond equipment distribution
  • Gaps in the way that hepatitis C prevention sector understands and addresses risk

Lead author Dr Joanne Bryant, Senior Research Fellow at the CSRH, said the report particularly highlighted the challenges of testing, diagnosis and care of Aboriginal people with hepatitis C.

"While we found that Aboriginal Australians living with hepatitis C were generally satisfied with their care, they were often subject to stigma and discrimination, which can create a barrier in accessing healthcare," Dr Bryant said. "Policies and programs need to be culturally tailored to address the unique needs and experiences of Aboriginal people living with hepatitis C and their communities."

The report found that most hepatitis C infections occur early in people's drug using pathways but many young people had limited knowledge about the availability of sterile injecting equipment.

In a survey of 210 socially marginalised young people at risk of transitioning to injecting drug use, a third (34.3%) of participants thought they knew where to obtain sterile needles, fewer (24.3%) could correctly identify a service, and the sources most commonly identified – hospitals (27.8%) and pharmacies (25.0%) – were not specifically needle distribution services.

"These findings suggest that needle distribution policies should focus less on getting 'at-risk' young people to visit primary needle and syringe programs and more on improving services that they already know about, such as hospitals and pharmacies, or finding ways of bringing sterile needles to them, such as through peer distribution," Dr Bryant said.

The report also notes that despite the majority of needle or syringe sharing occurring between sexual partners, the framing and delivery of harm reduction in Australia has little capacity to recognise intimate partnerships, including addressing the hepatitis C risks specific to them.

"Not only might more effective harm reduction strategies be achieved by moving to a practice framework that addresses the social context of injecting, including the experience of couples, the broader drug treatment and hepatitis C care sectors might also benefit from recognising the importance that partnership plays in the lives of couples who inject drugs," Dr Bryant said.

The report also examines risks factors, attitudes and knowledge of hepatitis B, and highlights that about one third of people living with the diseases are yet to be diagnosed and only 6% have been treated.

Stigma remains a factor influencing decisions about care and treatment of people living with hepatitis. But for those diagnosed with liver cancer, the says lack of English-language proficiency can be a barrier to accessing health services and understanding the implications of a cancer diagnosis.

"Our recommendations include a directory of Chinese-speaking medical practices and Chinese language interpretation services, the development of Cantonese and Mandarin language health promotional materials, and identifying opportunities to support family doctors and liver specialists," Dr Bryant said.

Professor Carla Treloar, Director of the CSRH, said 'Viral transmission happens in complex ways that are impacted by social context and the relationships of people at risk of acquiring . Within the exciting context of new generation hepatitis C treatments, there remains the need to continually innovate harm reduction programs in ways that reflect how transmission happens in the everyday.'

Explore further: Record numbers accessing hepatitis C treatment, but who is missing out?

More information: Annual Report of Trends in Behaviour 2017: Viral Hepatitis in Australia. unsworks.unsw.edu.au/fapi/data … f6bd8eeb6e?view=true

Related Stories

Record numbers accessing hepatitis C treatment, but who is missing out?

September 29, 2016
A mistrust of the health system and ongoing stigma from health workers against injecting drug users are two significant barriers that could prevent people living with hepatitis C from accessing and continuing life-saving ...

Latest research shows Australia on track to cure hepatitis C

February 21, 2017
More Australians have been treated for hepatitis C in the past 12 months than the last decade combined, following the listing of a new generation therapy on the Pharmaceutical Benefits Scheme.

From chronic to cured—could Australia be the first to eliminate hep C?

July 28, 2017
Australia is on track to eliminate hepatitis C by 2026, a new report released by the Kirby Institute on World Hepatitis Day shows.

World Hepatitis Day sets the stage for the elimination of viral hepatitis

July 28, 2017
Today, World Hepatitis Day, marks the first time that the global health community has come together to officially begin moving towards the elimination of viral hepatitis by 2030.

New research shows indigenous peoples are much more likely to be infected by hepatitis B and/or C

August 9, 2017
A new meta-analysis of global hepatitis data—presented at this year's World Indigenous Peoples' Conference on Viral Hepatitis in Anchorage, Alaska, USA (8-9 August)—shows that Indigenous Peoples are up to 10 times more ...

Hepatitis C nearly triples in US in 5 years

May 11, 2017
The number of hepatitis C infections have nearly tripled in the United States in the last five years, particularly among people in their 20s, researchers said Thursday.

Recommended for you

A multimodal intervention to reduce one of the most common healthcare-acquired infections

March 16, 2018
Surgical site infections are the most frequent health care-associated infections in developing countries. According to the World Health Organization (WHO), this type of infection can affect up to one-third of surgical patients ...

New imaging approach offers unprecedented views of staph infection

March 14, 2018
Eric Skaar, PhD, MPH, marvels at the images on his computer screen—3-D molecular-level views of infection in a mouse. "I'm pretty convinced that these are the most advanced images in infection biology," said Skaar, Ernest ...

Parasitic worms need their intestinal microflora too

March 14, 2018
Scientists at The University of Manchester have cast new light on a little understood group of worm infections, which collectively afflicts 1 in 4 people, mainly children—in the developing the world.

Compound scores key win in battle against antibiotic resistance

March 14, 2018
Researchers at Oregon State University have made a key advance in the fight against drug resistance, crafting a compound that genetically neutralizes a widespread bacterial pathogen's ability to thwart antibiotics.

Helicobacter creates immune system blind spot

March 13, 2018
The gastric bacterium H. pylori colonizes the stomachs of around half the human population and can lead to the development of gastric cancer. It is usually acquired in childhood and persists life-long, despite a strong inflammatory ...

Taking the jab (and the chill) out of vaccination

March 13, 2018
Scientists in Cairns (Australia) and Cardiff (Wales) have taken an important first step towards solving two problems that hinder access to vaccines: they need to be kept cool, and no one likes needles.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.